Literature DB >> 17565022

Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers.

Anna-Carin Olin1, Björn Bake, Kjell Torén.   

Abstract

BACKGROUND: The measurement of fractional exhaled nitric oxide (FENO) is used as a marker of airway inflammation. The aim of this study was to establish reference values of FENO for adults.
METHODS: FENO at a flow rate of 50 mL/s was analyzed in 3,376 adults using a chemiluminescence analyzer according to American Thoracic Society/European Respiratory Society guidelines. Blood samples were analyzed, and atopy was defined as the presence of specific IgE. All subjects responded to a respiratory questionnaire. Those who had never smoked (n = 1,803) were selected for this study. After the exclusion of subjects with physician-diagnosed asthma, asthma symptoms, ever wheezing, dry cough, or use of inhaled steroids, 1,131 healthy never-smokers remained, including 845 nonatopic and 286 atopic subjects.
RESULTS: Based on multiple regression modeling, we propose the following reference equation for healthy never-smoking adults: Ln(FENO) = 0.057 + 0.013 x height (in centimeters) + 0.0088 x age (in years). The residual SD was 0.51, and the explanatory value was 9%. In a model, based on nonatopic subjects alone, the reference equation obtained was slightly different, as follows: Ln(FENO) = -0.0026 + 0.013 x height (in centimeters) + 0.010 x age (in years). The residual SD for this equation was 0.48, and the explanatory value was 11%.
CONCLUSIONS: Normal values of FENO for adults may be predicted on the basis of age and height. However, as the reference equations only account for about 9 to 11% of the variation, the most important information that could be extracted from the study is that the upper limits of FENO range from 24.0 to 54.0 parts per billion, depending on age and height.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565022     DOI: 10.1378/chest.06-2928

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  35 in total

1.  Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.

Authors:  Raed A Dweik; Ronald L Sorkness; Sally Wenzel; Jeffrey Hammel; Douglas Curran-Everett; Suzy A A Comhair; Eugene Bleecker; William Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Elliot Israel; Nizar Jarjour; Wendy Moore; Stephen Peters; Gerald Teague; Benjamin Gaston; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2010-02-04       Impact factor: 21.405

2.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

3.  Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough.

Authors:  Patrizia Pignatti; Antonio Spanevello
Journal:  Ann Transl Med       Date:  2016-09

Review 4.  Asthma outcomes: biomarkers.

Authors:  Stanley J Szefler; Sally Wenzel; Robert Brown; Serpil C Erzurum; John V Fahy; Robert G Hamilton; John F Hunt; Hirohito Kita; Andrew H Liu; Reynold A Panettieri; Robert P Schleimer; Michael Minnicozzi
Journal:  J Allergy Clin Immunol       Date:  2012-03       Impact factor: 10.793

5.  The Effects of Aging on Exhaled Nitric Oxide (FeNO) in a North African Population.

Authors:  Sonia Rouatbi; Ines Ghannouchi; Helmi Bensaad
Journal:  Lung       Date:  2019-01-14       Impact factor: 2.584

6.  TGF-β2 reduces nitric oxide synthase mRNA through a ROCK-dependent pathway in airway epithelial cells.

Authors:  Jingjing Jiang; Steven C George
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-17       Impact factor: 5.464

7.  Modeling gas phase nitric oxide release in lung epithelial cells.

Authors:  Jingjing Jiang; Steven C George
Journal:  Nitric Oxide       Date:  2011-04-30       Impact factor: 4.427

8.  Hypersensitivity pneumonitis in a cluster of sawmill workers: a 10-year follow-up of exposure, symptoms, and lung function.

Authors:  Karl Færden; May Brit Lund; Trond Mogens Aaløkken; Wijnand Eduard; Per Søstrand; Sverre Langård; Johny Kongerud
Journal:  Int J Occup Environ Health       Date:  2014 Apr-Jun

9.  Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.

Authors:  Anna P Ralph; Tsin W Yeo; Cheryl M Salome; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Emiliana Tjitra; Richard Lumb; Graeme P Maguire; Ric N Price; Mark D Chatfield; Paul M Kelly; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2013-06-03       Impact factor: 5.226

10.  Exhaled nitric oxide in diagnosis and management of respiratory diseases.

Authors:  Abdullah A Abba
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.